AI assistant
Armata Pharmaceuticals, Inc. — Earnings Release 2003
Oct 30, 2003
34152_rns_2003-10-30_cc4267dd-08d3-4797-9a88-88a5f6b83c79.zip
Earnings Release
Open in viewerOpens in your device viewer
8-K 1 v94064e8vk.htm FORM 8-K Targeted Genetics Corporation Form 8-K PAGEBREAK
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 30, 2003
Targeted Genetics Corporation
(Exact name of registrant as specified in charter)
| Washington | 0-23930 | 91-1549568 |
|---|---|---|
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 1100 Olive Way, Suite 100, Seattle, Washington | 98101 |
|---|---|
| (Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code (206) 623-7612
Not Applicable
(Former name or former address, if changed since last report)
1 PAGEBREAK
TOC
TABLE OF CONTENTS
| Item 12. Results and Operations of Financial Condition. |
| SIGNATURES |
| EXHIBIT INDEX |
| EXHIBIT 99.1 |
/TOC
Table of Contents
link2 "Item 7. Exhibits."
Item 7. Exhibits.
(a) Financial statements of business acquired.
Not applicable.
(b) Pro forma financial information.
Not applicable.
(c) Exhibits.
| Exhibit | |
|---|---|
| No. | Description |
| 99.1 | Press Release of Targeted Genetics Corporation dated |
| October 30, 2003 |
link2 "Item 12. Results and Operations of Financial Condition."
Item 12. Results and Operations of Financial Condition.
On October 30, 2003, Targeted Genetics Corporation issued a press release announcing its financial results for the quarter ended September 30, 2003. A copy of the press release is furnished as Exhibit 99.1 and is incorporated into this current report by reference. link1 "SIGNATURES"
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| By: | /s/ Todd E. Simpson |
|---|---|
| Date: October 30, 2003 | Todd E. Simpson |
| Vice President, Finance and | |
| Administration and Chief Financial | |
| Officer, Secretary and Treasurer | |
| (Principal Financial and Accounting | |
| Officer) |
PAGEBREAK
Table of Contents
link1 "EXHIBIT INDEX"
EXHIBIT INDEX
| Exhibit | |
|---|---|
| No. | Description |
| 99.1 | Press Release of Targeted Genetics Corporation dated |
| October 30, 2003 |